No Data
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock
JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating
Needham Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $10
Generation Bio's Promising Advancements and Strategic Collaborations Drive Buy Rating
Generation Bio Says New Non-Human Primate Data Show Highly Selective In Vivo Delivery Of MRNA To T Cells With Cell-targeted Lipid Nanoparticle
Generation Bio Announces the Presentation of Preclinical Data on CtLNP and IqDNA at the ESGCT 31st Annual Congress
No Data
No Data